Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia.
Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes.
No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis.
Tongue Somatosensory-Evoked Potentials: Evaluation of the Afferent Trigeminal Pathway in Patients With Early Multiple Sclerosis.
[NMO Spectrum Disorders and Anti AQP4 Antibody].
Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease.
Inflammatory demyelinating diseases in children: an update.
Acute lumbosacral transverse myelitis.
Using Observational Analysis of Multiple Sclerosis Relapse to Design Outcomes-Based Contracts for Disease-Modifying Drugs: A Feasibility Assessment.
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.
Efficacy of lower fingolimod doses in the treatment of MS.
Knee muscle strength in multiple sclerosis: relationship with gait characteristics.
Term pregnancies and the clinical characteristics of multiple sclerosis: a population based study.
Disease activity and disability evolution under glatiramer acetate: A clinical approach.
Recruitment of participants to a multiple sclerosis trial: The CombiRx experience.
The essential role of t cells in multiple sclerosis: A reappraisal.
An epidemiological study of neuromyelitis optica in Isfahan.
Ranolazine Attenuates Mechanical Allodynia Associated with Demyelination Injury.
Objective and subjective measures reflect different aspects of balance in multiple sclerosis.
Few patients with neurodegenerative disorders require spinal surgery.
Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction.
Inadvertent foley catheterization of the ureter.
Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review.
Pages
« first
‹ previous
…
362
363
364
365
366
367
368
369
370
…
next ›
last »